PubMed · 1996 · 73 citations · 11 references
MedicineCardiologyHematologyCardiac TransplantationCell TherapyStem Cell TransplantationCell CryopreservationCryoprotectant ToxicityEngraftment MonitoringHeart TransplantationTransplant OutcomesTransplant-related ToxicitiesAutologous Stem Cell InfusionAutologous Stem Cell TherapyCardiovascular Complications After TransplantationContinuous MonitoringCryopreserved AllograftsCryoprotectant ActionFractionated TreatmentGraft Cryopreservation
The amount of transfused dimethyl sulfoxide (DMSO) is indicated as the major cause of the cryoprotectant-related toxicity in autologous stem cell recipients, with a high incidence of major cardiac side effects. In this study we tried to discover whether fractionated infusion of the total graft volume could prevent the DMSO-related major cardiovascular side effects. We conclude that continuous cardiac monitoring during and after fractionated infusions of DMSO-containing graft documented no major arrhythmias, with only seven episodes of asymptomatic sinus bradycardia.
11
Clinical toxicity of cryopreserved bone marrow graft infusion
JM Davis, SD Rowley, HG Braine et al. · Blood · 1990 · 245 citations · Full text
Medicine, Hematology, Surgery +14
Adverse reactions in patients transfused with cryopreserved marrow
DF Stroncek, SK Fautsch, LC Lasky et al. · Transfusion · 1991 · 188 citations
Cryopreservation and infusion of autologous peripheral blood stem cells.
Anne Kessinger, Kim Schmit-Pokorny, Douglas M. Smith et al. · PubMed · 1990 · 71 citations
Medicine, Cell Biology, Hematology +11